Laura A. Lane
Corporate Officer/Principal presso ELI LILLY AND COMPANY
Posizioni attive di Laura A. Lane
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/08/2022 | - |
Storia della carriera di Laura A. Lane
Precedenti posizioni note di Laura A. Lane
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Analista di Private Equity | 01/03/2019 | 01/10/2021 |
| Investitore di Private Equity | 01/10/2021 | 01/08/2022 | |
Virion Biotherapeutics Ltd.
 Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Virion Biotherapeutics Ltd. operates as a biotechnology company that develops novel therapeutics for respiratory viral infections. The firm focuses on prevention and treatment of influenza and respiratory syncytial virus. The company was founded by Nigel Dimmock and Andrew Easton in 2017 and is headquartered in Coventry, the United Kingdom. | Direttore operativo | 01/03/2015 | 30/06/2018 |
| Fondatore | 01/03/2015 | 30/06/2018 |
Formazione di Laura A. Lane
| University of Cambridge | Doctorate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 4 |
| Stati Uniti | 2 |
Posizioni
| Private Equity Analyst | 1 |
| Private Equity Investor | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Aziende private | 2 |
|---|---|
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
Virion Biotherapeutics Ltd.
Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Virion Biotherapeutics Ltd. operates as a biotechnology company that develops novel therapeutics for respiratory viral infections. The firm focuses on prevention and treatment of influenza and respiratory syncytial virus. The company was founded by Nigel Dimmock and Andrew Easton in 2017 and is headquartered in Coventry, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Laura A. Lane
- Esperienza
